384 related articles for article (PubMed ID: 11685488)
21. Metabolite analysis of [11C]flumazenil in human plasma: assessment as the standardized value for quantitative PET studies.
Ishiwata K; Itou T; Ohyama M; Yamada T; Mishina M; Ishii K; Nariai T; Sasaki T; Oda K; Toyama H; Senda M
Ann Nucl Med; 1998 Feb; 12(1):55-9. PubMed ID: 9559964
[TBL] [Abstract][Full Text] [Related]
22. Quantitative in vivo measurement of central benzodiazepine receptors in the brain of cats by use of positron-emission tomography and [11C]flumazenil.
Shimada Y; Kiyosawa M; Nariai T; Oda K; Toyama H; Ono K; Senda M; Ishiwata K
Am J Vet Res; 2003 Aug; 64(8):999-1002. PubMed ID: 12926592
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.
Holthoff VA; Koeppe RA; Frey KA; Penney JB; Markel DS; Kuhl DE; Young AB
Ann Neurol; 1993 Jul; 34(1):76-81. PubMed ID: 8390806
[TBL] [Abstract][Full Text] [Related]
24. 11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain.
Zhang MR; Kumata K; Maeda J; Yanamoto K; Hatori A; Okada M; Higuchi M; Obayashi S; Suhara T; Suzuki K
J Nucl Med; 2007 Nov; 48(11):1853-61. PubMed ID: 17978354
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of benzodiazepine receptors in human brain using the partial saturation method.
Delforge J; Spelle L; Bendriem B; Samson Y; Bottlaender M; Papageorgiou S; Syrota A
J Nucl Med; 1996 Jan; 37(1):5-11. PubMed ID: 8544001
[TBL] [Abstract][Full Text] [Related]
26. [11C]flumazenil PET: activity images versus parametric images for the detection of neocortical epileptic foci.
Niimura K; Muzik O; Chugani DC; Shen C; Chugani HT
J Nucl Med; 1999 Dec; 40(12):1985-91. PubMed ID: 10616875
[TBL] [Abstract][Full Text] [Related]
27. Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.
Debruyne D; Abadie P; Barre L; Albessard F; Moulin M; Zarifian E; Baron JC
Eur J Drug Metab Pharmacokinet; 1991; 16(2):141-52. PubMed ID: 1657612
[TBL] [Abstract][Full Text] [Related]
28. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.
Price JC; Mayberg HS; Dannals RF; Wilson AA; Ravert HT; Sadzot B; Rattner Z; Kimball A; Feldman MA; Frost JJ
J Cereb Blood Flow Metab; 1993 Jul; 13(4):656-67. PubMed ID: 8391018
[TBL] [Abstract][Full Text] [Related]
29. Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog.
Villemagne VL; Horti A; Scheffel U; Ravert HT; Finley P; Clough DJ; London ED; Wagner HN; Dannals RF
J Nucl Med; 1997 Nov; 38(11):1737-41. PubMed ID: 9374343
[TBL] [Abstract][Full Text] [Related]
30. Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography.
Abadie P; Baron JC; Bisserbe JC; Boulenger JP; Rioux P; Travère JM; Barré L; Petit-Taboué MC; Zarifian E
Eur J Pharmacol; 1992 Mar; 213(1):107-15. PubMed ID: 1323469
[TBL] [Abstract][Full Text] [Related]
31. Carbon-11 and iodine-123 labelled iomazenil: a direct PET-SPET compari son.
Westera G; Buck A; Burger C; Leenders KL; von Schulthess GK; Schubiger AP
Eur J Nucl Med; 1996 Jan; 23(1):5-12. PubMed ID: 8586102
[TBL] [Abstract][Full Text] [Related]
32. Visualization of alpha5 subunit of GABAA/benzodiazepine receptor by 11C Ro15-4513 using positron emission tomography.
Maeda J; Suhara T; Kawabe K; Okauchi T; Obayashi S; Hojo J; Suzuki K
Synapse; 2003 Mar; 47(3):200-8. PubMed ID: 12494402
[TBL] [Abstract][Full Text] [Related]
33. Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study.
Koepp MJ; Richardson MP; Brooks DJ; Cunningham VJ; Duncan JS
Epilepsia; 1997 Oct; 38(10):1089-97. PubMed ID: 9579955
[TBL] [Abstract][Full Text] [Related]
34. In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat.
Dedeurwaerdere S; Gregoire MC; Vivash L; Roselt P; Binns D; Fookes C; Greguric I; Pham T; Loc'h C; Katsifis A; Hicks RJ; O'Brien TJ; Myers DE
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):958-65. PubMed ID: 19205698
[TBL] [Abstract][Full Text] [Related]
35. Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography.
Foged C; Halldin C; Loc'h C; Mazière B; Pauli S; Maziére M; Hansen HC; Suhara T; Swahn CG; Karlsson P; Farde L
Eur J Nucl Med; 1997 Oct; 24(10):1261-7. PubMed ID: 9323267
[TBL] [Abstract][Full Text] [Related]
36. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
[TBL] [Abstract][Full Text] [Related]
37. PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil.
Pauli S; Liljequist S; Farde L; Swahn CG; Halldin C; Litton JE; Sedvall G
Psychopharmacology (Berl); 1992; 107(2-3):180-5. PubMed ID: 1319600
[TBL] [Abstract][Full Text] [Related]
38. Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.
Syvänen S; Labots M; Tagawa Y; Eriksson J; Windhorst AD; Lammertsma AA; de Lange EC; Voskuyl RA
J Nucl Med; 2012 Dec; 53(12):1974-83. PubMed ID: 23143088
[TBL] [Abstract][Full Text] [Related]
39. Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors.
Millet P; Graf C; Buck A; Walder B; Westera G; Broggini C; Arigoni M; Slosman D; Bouras C; Ibáñez V
J Cereb Blood Flow Metab; 2000 Nov; 20(11):1587-603. PubMed ID: 11083234
[TBL] [Abstract][Full Text] [Related]
40. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole.
Tipre DN; Zoghbi SS; Liow JS; Green MV; Seidel J; Ichise M; Innis RB; Pike VW
J Nucl Med; 2006 Feb; 47(2):345-53. PubMed ID: 16455642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
